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Abstract
This study assessed the effects of Coprinus comatus cap (CCC) on adipogenesis in 3T3-L1 adipocytes and the effects of CCC
on the development of diet-induced obesity in rats. Here, we showed that the CCC has an inhibitory effect on the adipocyte
differentiation of 3T3-L1 cells, resulting in a significant decrease in lipid accumulation through the downregulation of
several adipocyte specific-transcription factors, including CCAAT/enhancer binding protein b, C/EBPd, and peroxisome
proliferator-activated receptor gamma (PPARc). Moreover, treatment with CCC during adipocyte differentiation induced a
significant down-regulation of PPARc and adipogenic target genes, including adipocyte protein 2, lipoprotein lipase, and
adiponectin. Interestingly, the CCC treatment of the 3T3-L1 adipocytes suppressed the insulin-stimulated Akt and GSK3b
phosphorylation, and these effects were stronger in the presence of an inhibitor of Akt phosphorylation, LY294002,
suggesting that CCC inhibited adipocyte differentiation through the down-regulation of Akt signaling. In the animal study,
CCC administration significantly reduced the body weight and adipose tissue weight of rats fed a high fat diet (HFD) and
attenuated lipid accumulation in the adipose tissues of the HFD-induced obese rats. The size of the adipocyte in the
epididymal fat of the CCC fed rats was significantly smaller than in the HFD rats. CCC treatment significantly reduced the
total cholesterol and triglyceride levels in the serum of HFD rats. These results strongly indicated that the CCC-mediated
decrease in body weight was due to a reduction in adipose tissue mass. The expression level of PPARc and phospho-Akt
was significantly lower in the CCC-treated HFD rats than that in the HFD obesity rats. These results suggested that CCC
inhibited adipocyte differentiation by the down-regulation of major transcription factor involved in the adipogenesis
pathway including PPARc through the regulation of the Akt pathway in 3T3-L1 cells and HFD adipose tissue.
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Introduction
Obesity is associated with various diseases, particularly cardio-
vascular disease, type 2 diabetes, and metabolic diseases, including
metabolic syndrome [1]. Obesity is a medical condition in which
excess body fat has accumulated to such a high extent that it may
cause adverse effects on health, leading to a reduced life
expectancy and/or increased health problems. Thus, adipogenesis
is closely related to the etiologies of obesity and obesity-related
metabolic disorders [2]. Cellular and molecular studies concerning
obesity have shown that increased numbers of adipocytes, which
are associated with alterations in size, are triggered by genetic or
dietary factors [3]. Increases in either adipocyte cell number or the
size of the individual adipocytes, due to increased lipid accumu-
lation and adipocyte differentiation, result in increased lipid
deposition.
Adipocyte differentiation involves an elaborate network of
transcription factors that regulate the expression of numerous
genes responsible for the phenotypes of mature adipocytes [4].
The differentiation of preadipocytes into adipocytes is accompa-
nied by a dramatic increase in the expression of CCAAT/
enhancer binding protein b (C/EBPb) and C/EBPd, which
transcriptionally activate the C/EBPa and peroxisome prolifera-
tor-activated receptor gamma (PPARc) genes by binding to the C/
EBP regulatory elements [5,6]. PPARc is considered the master
regulator of adipocyte differentiation and drives the expression of
adipocyte-specific genes. The activation of PPARc is necessary for
the expression of adipocyte-specific genes, such as adipocyte
protein 2 (aP2), lipoprotein lipase (LPL), and adiponectin and fatty
acid synthase (FAS), which facilitates the cytoplasmic storage of
massive amounts of triglycerides [7].
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The phosphatidylinositol 3-kinase (PI3-K)/Akt signaling path-
way plays a key role in regulating adipocyte differentiation and
adipogenesis [8,9]. The enforced expression of the constitutively
active form of Akt increases glucose uptake and promotes
spontaneous adipocyte differentiation in 3T3-L1 adipocytes [10].
In contrast, the RNAi-mediated decrease in Akt expression
blocked the differentiation of 3T3-L1 cells [11], and mouse
embryonic fibroblasts (MEFs) lacking Akt display an inability to
differentiate into adipocytes and reduced body fat [12,13]. These
results highlight the pivotal role of Akt in adipogenic regulation in
adipose tissue.
Akt phosphorylates and regulates a number of substrates
involved in a diverse array of biological processes [14], many of
which can enhance adipogenesis. Moreover, the Akt signaling
pathway regulates the expression of C/EBPa and PPARc during
adipogenesis in 3T3-L1 cells [15], and 3T3-L1 cells lacking Akt
could not induce PPARc expression at the initiation of the
adipogenesis program. The overexpression of PPARc in Akt-
deficient MEFs rescued the severe adipogenesis defect [12].
Interestingly, insulin signaling activates Akt through PI3K and
induces the serine/threonine phosphorylation of the downstream
target Glycogen synthase kinase 3 beta (GSK3b), which is involved
in adipocyte differentiation of preadipose cells [16,17]. Addition-
ally, GSK3b is a critically important protein kinase in adipocyte
differentiation as it phosphorylates a number of substrates,
including the transcription factors b-catenin, C/EBPb, C/EBPa,
and glycogen synthase (GS).
Mushrooms and their components have been reported to have
numerous positive health benefits, mainly on the basis of in vitro
and in vivo animal trials. Coprinus comatus (CC), a novel
cultivated edible mushroom found in Korea, has immense
potential as a source of valuable medicinal compounds. Many
physiological functions of CC have been reported, such as
hypoglycemic, immunomodulation, hypolipidemic, antitumor
and antibacterial effects [18,19]. Mycelia extracts of CC have
been shown to exhibit antioxidant potential [20] and hypoglyce-
mic effects, as well as improved glucose tolerance [21]. Moreover,
CC extracts exhibited hypolipidemic effects and antioxidant
properties in diabetic mice, suggesting that their antioxidant
activity could be directly or indirectly responsible for its
hypoglycemic and hypolipidemic properties [22].
Many species of mushrooms have been investigated for their use
as potential anti-obesity agents, and understanding how CC
extracts function during adipogenesis is essential to developing
new treatments for obesity. However, there have been few studies
on the role of Coprinus comatus cap (CCC) in the regulation of
adipogenesis and obesity. In the present study, we investigated the
inhibitory effect of CCC on adipocyte differentiation in 3T3-L1
cells and its anti-obesity effects in high fat diet (HFD)-induced
obese rats.
Materials and Methods
Preparation of Coprinus comatus cap extracts (CCCE)
Fresh fruit bodies of Coprinus comatus (CC) were obtained from
the Bio Company (Moonsan, Korea). The caps of the fruit bodies
were peeled off and air-dried in an oven, which began at 30uC,
then increased 5uC every 3 h until it reached 40uC. The dried cap
was milled into a powder (40 mesh). The Coprinus comatus caps
(CCC) (15 g) were ground in an 80% (v/v) ethanol solution using a
mixer, followed by extraction of the samples for 3 days with
vigorous shaking at room temperature, and filtering through
Whatman No. 1 filter paper. The ethanolic extracts of the
Coprinus comatus caps (CCC) were concentrated using rotary-
vacuum evaporation at 50uC and then freeze-dried.
Measurement of total phenolic content using Folin-
Ciocalteu assay
The total phenolic content of the CCCE was determined using
a spectrophotometer according to the Folin-Ciocalteu colorimetric
method [23]. Because quercetin is one of the polyphenol
compounds found in CCC, the total phenolic content of ethanol
extract of CCC was expressed as mg quercetin (Sigma-Aldrich,
USA) equivalents (QE)/g.
Measurement of total flavonoids
The total flavonoid content was determined as previously
described [24] with slight modifications. Briefly, 0.25 mL of
CCCE (100 mg/mL) was added to a tube containing 1 mL of
double-distilled water. Next, 0.075 mL of 5% NaNO2, 0.075 mL
of 10% AlCl3 and 0.5 mL of 1 M NaOH were added sequentially
at 0, 5 and 6 min. Finally, the volume of the reacting solution was
adjusted to 2.5 mL with double-distilled water. The solution had
an absorbance of 410 nm that was detected using an Ultrospec
2100 Pro Spectrophotometer (Section 3.3). The results were
expressed in mg quercetin equivalents (QE)/g.
Measurement of free radical scavenging activity using
DPPH assay
The free radical scavenging activity of CCCE (100 mg/mL in
DW) was measured using the method of Brand-Williams [25], with
some modification. The inhibition percentage was calculated using
the following equation: Inhibition % = [(absorbance of control-
absorbance of sample)/absorbance of control]6100. The absor-
bance was measured using a spectrophotometer (Ultrospec 2100
pro; Amersham Pharmacia Biotech Co., Piscataway, NJ, USA).
Measurement of superoxide anion (O2N2) radical
scavenging and hydroxyl (OHN) radical scavenging
activity
Superoxide radicals were generated according to a method
described in a previous paper [26]. The samples (100 mg/mL in
DMSO) were added to the reaction solution containing 100 mL of
30 mM EDTA (pH 7.4), 10 mL of 30 mM hypoxanthine in
50 mM NaOH, and 200 mL of 1.42 mM nitroblue tetrazolium
(NBT). After the solution was preincubated at room temperature
for 3 min, 100 mL of 0.5 U/mL xanthine oxidase was added to the
mixture, and the volume was brought up to 3 mL with 50 mM
phosphate buffer (pH 7.4). After the solution was incubated at
room temperature for 20 min, the absorbance was measured at
560 nm. The reaction mixture without xanthine oxidase was used
as a blank (A1). The samples (A2) were added to the reaction
mixture, in which O2N2 was scavenged, thereby inhibiting the
reduction of NBT. The absorbance was measured, and the
decrease in O2N2 was represented by A2-A1. The scavenging
activity on the superoxide anion radical (SRSA) was calculated
using the following equation: SRSA % = (A2 2 A1/A1)6100.
The scavenging activity of the samples (100 mg/mL) in DMSO on
the hydroxyl radical (OHN) was measured using the deoxyribose
method [27] with a slight modification. The deoxyribose assay was
performed in 10 mM phosphate buffer (pH 7.4) containing
2.5 mM deoxyribose, 1.5 mM H2O2, 100 mM FeCl3, 104 mM
EDTA, and the test sample (0.5 mg/mL). The reaction was
started by adding ascorbic acid to a final concentration of 100 mM.
The reaction mixture was incubated for 1 h at 37uC in a water-
bath. After incubation, the color was developed by the addition of
Anti-Obesity Effects of Coprinus comatus Cap
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0.5% thiobarbituric acid followed by addition of ice-cold 2.8%
trichloroacetic acid in 25 mM NaOH and incubation for 30 min
at 80uC. A control was performed without the samples (A1). The
samples (A2) were cooled on ice, and the absorbance was
measured at 532 nm. The hydroxyl radical scavenging activity
(HRSA) was calculated using the following equation: HRSA% =
(A12 A2/A1)6100.
Cell culture
Mouse 3T3-L1 preadipocytes were purchased from the Korean
Cell Line Bank (Seoul, Korea) and cultured as described elsewhere
[5]. In brief, cells were cultured in Dulbecco’s modified eagle high-
glucose medium (DMEM) supplemented with 10% calf serum at
37uC in a humidified atmosphere of 5% CO2. At 1 day
postconfluence (designated ‘‘day 0’’), cell differentiation was
induced with a mixture (DMI) of 0.5 mM 3-isobutyl-1-methyl-
xanthine, 100 mM indomethacin, 0.25 mM dexamethasone and
167 nM insulin in DMEM containing 10% FBS. The 3-isobutyl-1-
methylxanthine (MIX), dexamethasone (DEX), indomethacin, and
Oil-Red O were obtained from Sigma-Aldrich (St. Louis, MO,
USA). The medium was changed every 2 days. CCCs were added
to the culture medium of the adipocytes on day 0. The cells were
treated with 0, 40, or 150 mg/mL CCC extracts every day. After
treatment with CCC for 3, 5 and 7 days, the 3T3-L1 adipocytes
were lysed for western blot analysis. To analyze cell viability, the
cytotoxicity of the CCC was evaluated using 3-(4, 5-demethylthia-
zol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT). A549 human
lung carcinoma cells obtained from the Korean Cell Line Bank
(Seoul, Korea) were cultured in RPMI 1640 medium supplement-
ed with 10% FBS and 1% penicillin/streptomycin in a 5% CO2
atmosphere at 37uC. Cells grown to 70–80% confluency were
untreated (control) or treated with 40 or 150 mg/ml CCC in the
absence or presence of insulin (50 ng/ml) or rosiglitazone (10 mM)
in complete growth medium.
Oil-Red O staining and triglyceride assay
For Oil-Red O staining, the cells were gently washed with
phosphate-buffered saline (PBS) and stained with filtered Oil-Red
O solution (60% isopropanol and 40% water) for 30 min. After
staining, the Oil-Red O staining solution was removed, and the
plates were rinsed with water and dried. The stained lipid droplets
were viewed on an Olympus microscope (Tokyo, Japan). To
analyze the content of the cellular triglycerides, the cells were
washed with PBS, scraped into 200 mL of PBS and sonicated for
1 min. When the elective PI3K inhibitor LY294002 (Sigma-
Aldrich, St. Louis, MO, USA) was used, the 3T3-L1 cells were
incubated with or without 10 mM LY294002 in the presence or
absence of CCC for 6 days. The lysates were assayed for their total
triglyceride content using assay kits from Sigma-Aldrich (St. Louis,
MO, USA) and for cellular protein using the Bio-Rad protein
assay (CA, USA). The results were expressed as mg of triglyceride
per mg of cellular protein.
RT-PCR
Total RNA was isolated from 3T3-L1 adipocytes and A549
human lung cells using the Trizol reagent (Invitrogen, CA, USA).
One microgram of total RNA was used for first strand cDNA
synthesis with oligo (deoxythymidine) primers and Superscript II
reverse transcriptase (Invitrogen, CA, USA). The target cDNA was
amplified using the following primers: C/EBPb, 59-GACTACG-
CAACACACGTGTAACT-39 and 59-CAAAACCAAAAACAT-
CAACAACCC-39; C/EBPd, 59-GATCTGCACGGCCTGTTG-
TA-39 and 59-CTCCACTGCCCACCTGTCA-39; PPARc, 59-
TTTTCAAGGGTGCCAGTTTC-39 and 59-AATCCTTGG-
CCCTCTGAGAT-39; C/EBPa, 59-TTACAACAGGCCAGG-
TTTCC-39 and 59-GGCTGGCGACATACAGATCA-39; LPL,
5-TCCTCTGACATTTGCAGGTCTATC-39 and 59-GTGAA-
TCCAGTTATGGGTTCCAC-3; aP2, 5-AACACCGAGATTT-
CCTTCAA-39 and 59-TCACGCCTTTCATAACACAT-3; adi-
ponectin, 59-ACCTACGACCAGTATCAGGAAAAG-39 and 59-
ACTAAGCTGAAAGTGTGTCGACTG-39; b-actin (control),
59-GACAACGGCTCCGGCATGTGCAAAG-39 and 59-TTCA-
CGGTTGGCCTTAGGGTTCAG-39. The amplification cycles
included denaturation at 95uC for 50 sec, annealing at 55uC for
1 min and elongation at 72uC for 50 sec. After 30 cycles, the PCR
products were separated by electrophoresis on a 1.5% agarose gel
for 30 min at 100 V. The gels were stained with 1 mg/ml
ethidium bromide and visualized with UV light using the BIO-
RAD Gel Doc image analysis software (BIO-RAD Laboratories
Inc., CA, USA).
Luciferase reporter activity assay
The plasmids encoding PPARc and PPARc-Luc were kindly
provided by Dr. Jae Bum Kim of Seoul National University. The
control plasmid encoding Renilla luciferase and the Dual-
luciferase assay kit were purchased from Promega (www.
promega.com). Because CHO cells do not express PPARc, a
mixture containing the PPARc, RXRa, PPARc-Luc, and Renilla-
Luc plasmids were co-transfected into the CHO cells using the
Lipofectamine 2000 reagent (Invitrogen, USA) according to the
manufacturer’s instruction. After transfection, the cells were
treated with 100 mM rosiglitazone (PPARc agonist) in the absence
or presence of CCC for 24 h. The post-transfection luciferase
activities were measured using the Dual-Luciferase Reporter Assay
System (Promega, Madison, WI) using a GloMax20/20 luminom-
eter (Turner Biosystems, Sunnyvale, CA). The results were
normalized to the Renilla luciferase activity.
Measurement of Glucose uptake
Glucose uptake activity was measured using a fluorescent D-
glucose analogue 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-
2-deoxy-D-glucose (2-NBDG) (Invitrogen, Carlsbad, USA) in
3T3-L1 cells as a previously described method with slight
modifications [28]. Briefly, 3T3-L1 preadipocytes were differen-
tiated with various concentrations (10, 40, and 150 mg/ml) of
CCC or DMSO for 6 days in 6 well plates. After washing,
differentiated 3T3-L1 cells were treated with or without a given
concentrations of CCC and Insulin in the absence or presence of
10 mM 2-NBDG for 2 h. Then, cells were washed twice with PBS,
the fluorescence intensity of cellular 2-NBDG in each well was
measured at an excitation wavelength of 485 nm and an emission
wavelength of 530 nm using Fluorescent microplate reader
(Molecular Devices, USA).
Western blot analysis
Western blot analysis was performed according to standard
procedures. Briefly, 3T3-L1 cells, A549 human lung cells, and
epididymal fat pads were homogenized in lysis buffer containing
50 mM Tris-HCl (pH 8.0), 0.4% Nonidet P-40, 120 mM NaCl,
1.5 mM MgCl2, 0.1% SDS, 2 mM phenylmethylsulfonyl fluoride,
80 mg/mL leupeptin, 3 mM NaF and 1 mM DTT. The cell
lysates were separated by 10% SDS-polyacrylamide gel electro-
phoresis, transferred onto a polyvinylidene fluoride membrane
(Amersham Pharmacia, England, UK), blocked with 5% skim milk
and hybridized with primary antibodies. The PPARc, C/EBPb,
C/EBPa, aP2, Akt, and GSK3b antibodies were purchased from
Cell Signaling, and the monoclonal b-actin antibody was
purchased from Chemicon. The HRP-labeled mouse anti-rabbit
Anti-Obesity Effects of Coprinus comatus Cap
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IgG antibody was purchased from Jackson ImmunoResearch. The
chemiluminescence kit was purchased from Pierce (Rockford, IL).
After incubation with horseradish peroxidase-conjugated second-
ary antibody at room temperature, the immunoreactive proteins
were detected using a chemiluminescent ECL assay kit (Amersham
Pharmacia, UK) according to the manufacturer’s instructions.
Animal experiments. The study protocol was approved by
the Animal Care and Use committee of Gyeongsang National
University (Approval Number: GNU-121213-R0049). Five-week-
old male Sprague-Dawley (SD) rats, weighing approximately
160 g, were purchased from the Central Lab. Animal Inc. (Seoul,
Korea). All rats were housed in polycarbonate cages in a room
maintained at 22uC and 55% relative humidity. The room was
exposed to alternating 12 h periods of light and dark. The rats
were randomly divided into the following 4 groups: group fed a
regular diet (RD, n= 10); group fed a high-fat diet (HFD, rodent
diet with 60% kcal fat, Research Diet, Korea); and treatment
groups fed a high-fat diet plus CCC at 60 mg/kg (CCC 60) or
200 mg/kg (CCC 200). All of the rats were allowed free access to
food and water for 5 weeks. Food intake was measured daily, and
the rats were weighed every two days. Obese rats were generated
by feeding the rats a high-fat diet (HFD).
Biochemical assays
After 5 weeks on experimental diets, the rats were euthanized,
and the tissues were dissected out and analyzed. The body and
fatty tissue weights were measured with sensitivity limits of 0.1 g
and 0.01 g, respectively. The body mass index was calculated by
dividing the weight (g) by the square of the body length (cm2).
Blood was collected from each rat, stored at 37uC for 30 min, and
centrifuged at 4000 g at 4uC for 10 min to obtain the plasma. The
epididymal fat pad and perirenal fat pad were excised, weighed
and stored at 220uC until assayed. The concentrations of plasma
triglycerides (TG), total cholesterol (TC), and high-density
lipoprotein (HDL)-cholesterol were assayed enzymatically using
commercial kits (Asan phams, Co., Korea).
Histological Analysis
The epididymal fat pads and liver tissues was removed and fixed
in 10% neutral buffered formalin. The fat pads and livers were
subsequently embedded in paraffin, sectioned into 5 mm sections
(Leica, Wetzlar, Germany), and stained with hematoxylin-eosin for
microscopic assessment (Olympus, Tokyo, Japan). Three different
cross-sectional areas and their cell populations were calculated
using an image analysis program (Image-Pro Plus 6.0).
Statistical analysis
The data are expressed as the mean 6 SD. The significant
differences in the treatment means were determined using
ANOVA and Duncan’s multiple range tests at p,0.05.
Results
Total phenol content (TPC) and total flavonoid content
(TFC) of CCCE
The TPC and TFC contents of the CCCE were found to be
15.561.23 mg quercetin equivalent/g, and 3.3460.67 mg quer-
cetin equivalent/g extract, respectively (Table 1).
DPPH, hydroxyl, and superoxide anion radical scavenging
activity
The antioxidant properties were summarized in Table 1. The
CCCEs exhibited potent DPPH radical scavenging activity. The
hydroxyl radical scavenging activity of the CCCEs was assessed by
the reduction of nitroblue tetrazolium, and the CCCEs inhibited
hydroxyl radical generation. The extract was found to possess
potent antioxidant activity against superoxide radicals.
CCC extract inhibits lipid accumulation during the
differentiation of 3T3-L1 preadipocytes
To examine the anti-adipogenic effect of CCC on the
differentiation of preadipocytes into adipocytes, 3T3-L1 preadi-
pocytes were treated with DMI in the presence or absence of 40 or
150 mg/mL CCC for 7 days. The 3T3-L1 preadipocytes were fully
differentiated at 7 days after induction with the DMI mixtures.
Lipid accumulation, as a major marker of adipogenesis, was
quantified at day 7 by Oil-Red O staining. The triglycerides from
the fully differentiated adipocytes on day 7 were stained with Oil-
Red O staining solution, which stains lipid droplets to indicate
lipid accumulation. The cells treated with lower concentrations of
CCC (40 mg/mL) showed a high level of lipid droplet staining,
whereas the cells incubated with 150 mg/mL CCC exhibited
markedly reduced lipid staining on differentiation day 7 (Fig. 1A).
Microscopic observations of the Oil-Red O staining showed
gradual reductions in the amounts of lipid droplets with increasing
concentrations of CCC in a dose-dependent manner, demonstrat-
ing that treatment with CCC attenuated lipid accumulation in the
3T3-L1 adipocytes (Fig. 1B). Similar effects on lipid accumulation
with the same treatment were observed by measuring the
intracellular triglyceride (TG) content on days 3, 5 and 7 of the
differentiation period in 3T3-L1 cells. The results show that
treatment with CCC reduced the triglyceride content and that the
inhibition of intracellular TG in 3T3-L1 adipocytes occurred in a
dose-dependent manner and was dramatically reduced by 21%
and 43% at concentrations of 40 and 150 mg/mL of CCC on day
7, respectively (Fig. 1C).
To examine the cytotoxic effects of CCC on the differentiation
of 3T3-L1 preadipocytes, we induced 3T3-L1 cells to differentiate
by treating them with DMI mixtures every 2 days in the presence
or absence of CCCE. The cells were treated for 7 days with
various concentrations of CCC, ranging from 0 to 150 mg/mL,
and were then subjected to MTT assays on days 3, 5 and 7 after
Table 1. Antioxidant capacities, total phenolic and flavonoids content of the CCC extracts.
DPPHa HRSAb SRSAc TPCd (mgQE/g) Flavonoid (mgQE/g)
CCC 12.360.85y 14.260.78z 43.361.4z 15.561.23y 3.360.67x
aDPPH, DPPH radical scavenging activity;
bHRSA, hydroxyl radial scavenging activity;
cSRSA, superoxide anion radical scavenging activity;
dTPC, total phenolic acid. Total phenolic acid and total flavonoid content are expressed as milligrams of quercetin equivalent (QE)/g of extract.
x–zThe values are presented as the mean 6 SD. P,0.01 represents a significant difference between the samples (n = 4).
doi:10.1371/journal.pone.0105809.t001
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the initiation of differentiation. The results of the MTT assay
showed that concentrations of up to 150 mg/mL CCC did not
decrease the cell viability (Fig. 1D). The CCC treatments had no
effect on cell cytotoxicity up to 150 mg/mL (Fig. 1D). Taken
together, these results clearly indicated that the inhibitory effects of
CCC on lipid droplet formation and triglyceride accumulation
were not due to cytotoxicity. From these results, we elucidated that
CCC inhibited adipocyte differentiation in 3T3-L1 cells.
CCC inhibits the mRNA and protein expression of
transcription factors and adipocyte markers during
adipogenesis
Adipogenesis is accompanied by increased expression of
adipogenic transcription factors and adipocyte-specific genes. To
examine the effect of CCC on the expression of adipogenic
transcription factors, mRNA expression levels of PPARc and the
C/EBP family were measured during the differentiation of 3T3-L1
cells in the presence or absence of CCC. On days 3, 5, and 7, we
examined the expression of the adipocyte-specific transcription
factors, C/EBPb, C/EBPd, PPARc and C/EBPa. The mRNA
levels of C/EBPb, d, a and PPARc were significantly increased
following induction of adipogenesis on days 3, 5, and 7; however,
treatment with CCC reduced the mRNA levels of C/EBPb, d, and
PPARc in a time- and concentration-dependent manner (Fig. 2A
and B). Western blot analysis confirmed that the expression of C/
EBPb and PPARc was significantly down-regulated in the
presence of 150 mg/ml of CCC extract compared to the control
adipocytes that were induced by the DMI mixtures (Fig. 2C). In
addition, CCC also inhibited PPARc mRNA expression in A549
lung cancer cells (Fig. 2D), indicating that CCC affected the
expression of PPARc in DMI-independent manner. RT-PCR
analysis showed that the mRNA expression levels of the genes
controlling adipogenesis and adipocyte fatty acid metabolism,
including lipoprotein lipase (LPL), fatty acid binding protein (aP2),
and adiponectin, were also significantly increased after the
induction of adipogenesis in 3T3-L1 cells; however, the presence
of CCC resulted in the down-regulation of LPL, aP2, and
adiponectin expression in dose-dependent manner compared to
the differentiated adipocytes (Fig. 2). The patterns of adipogenic
protein expression were similar to the patterns of adipogenic
mRNA expression. We further investigated whether the reduction
of PPARc by CCC regulated the expression of its target gene, aP2.
The treatment of CCC significantly inhibited the expression of
aP2 in a dose-dependent manner during the differentiation of
3T3-L1 cells (Fig. 2C). Intriguingly, although the expression of
PPARc was reduced in the presence of CCC, there was no
significant change in C/EBPa mRNA or protein expression
compared to the control cells that were differentiated with the
DMI mixtures (Fig. 2A and C). These results suggest that CCC
obviously inhibited lipogenesis and adipogenesis through the
down-regulation of the key adipogenic genes, C/EBPb, C/EBPd,
PPARc and aP2. Next, to further investigate whether CCC could
inhibit the transcriptional activity of PPARc, the PPARc
expression plasmid and the PPARc luciferase reporter construct
driven by a promoter containing three repeats of the PPARc
binding site were co-transfected into CHO cells. We found that
CCC significantly suppressed the rosiglitazone-induced PPARc
transcriptional activity (Fig. 2E). Together, these results demon-
strated that CCC prevented adipocyte differentiation through an
antagonistic effect on PPARc transcriptional activity.
The Akt/GSK3b signaling pathway participated in the
regulation of adipocyte differentiation by CCC in 3T3-L1
cells
To determine whether CCC affects the Akt signaling pathway,
3T3-L1 adipocytes were treated with DMI in the presence or
absence of CCC. The insulin-mediated serine phosphorylation
(Ser473) of Akt was increased following the DMII-induced
differentiation of 3T3-L1 cells. However, the treatment of 3T3-
L1 cells with 40 mg/ml or 150 mg/ml of CCC decreased the levels
of Akt phosphorylation on day 5. Moreover, the exposure of 3T3-
L1 cells to 150 mg/ml CCC during the 7 day adipocyte
differentiation period dramatically inhibited the increase in the
serine phosphorylation of Akt caused by the insulin treatment
(Fig. 3A). Because the insulin-induced Akt phosphorylation leads
to the serine 9 phosphorylation (Ser9) of GSK3b, the levels of
GSK3b serine phosphorylation were examined. The expression of
wild type GSK3b was not altered by CCC treatment, whereas
CCC treatment significantly decreased the amount of serine
phosphorylation on GSK3b in a dose-dependent manner on days
5 and 7 of the 3T3-L1 cell differentiation period (Fig. 3B). To
investigate whether CCC had a role in phosphorylating Akt at
Ser473, we treated A549 lung cancer cells as shown in Fig. 3C and
performed western blot analysis. In agreement with the effects of
CCC in the 3T3-L1 adipocytes, CCC attenuated insulin-induced
Akt phosphorylation in A549 lung cancer cells. Taken together,
these results demonstrated that the activation of phosphorylated
Akt was inhibited by CCC, which in turn suppressed the
phosphorylation of its substrate kinase, GSK3b.
CCC inhibited 3T3-L1 adipocyte differentiation through
the Akt signaling pathway
To further investigate whether the PI3K/Akt signaling pathway
was directly involved in the inhibition of adipocyte differentiation
by CCC, we examined whether CCC acted through the PI3K/
Akt pathway using LY294002, a specific inhibitor of PI3K/Akt.
Following the induction of differentiation, 3T3-L1 cells were
treated with either CCC alone or a combination of CCC and
10 mM LY294002 for 6 days. After treatment with an MDI
mixture for 6 days, the differentiated 3T3-L1 cells had a much
Figure 1. CCC inhibits lipid accumulation during the differentiation of 3T3-L1 preadipocytes. (A) Insulin-induced differentiation of 3T3-L1
adipocytes was repressed by CCC. Confluent 3T3-L1 preadipocytes were differentiated into adipocytes in DMI medium containing different
concentrations (0, 40, or 150 mg/ml) of CCC for 7 days (from day 0 to 7). (A) The insulin-induced differentiation of 3T3-L1 adipocytes was repressed by
CCC treatment. Oil-Red O staining was performed on day 7 after the induction of differentiation. DMI: Adipogenic differentiation medium (0.5 mM 3-
IBMX, 100 mM indomethacin, 0.25 mM dexamethasone and 167 nM insulin). CCC: Coprinus comatus cap extract. (B) Microscopic observations of the
Oil-Red O staining showed a gradual reduction in the lipid content of the 3T3-L1 adipocytes after CCC treatment. (C) Effects of CCC extract on
intracellular triglyceride accumulation in 3T3-L1 adipocytes. The triglyceride content was significantly reduced by CCC treatment on days 3, 5, and 7
after the induction of differentiation in 3T3-L1 cells. The data shown are representative of at least three independent experiments. The values are
presented as the mean 6 SD. The bars with different letters are significantly different (*p,0.05) as determined by Duncan’s multiple range test. (D)
Effects of CCC on cell cytotoxicity in 3T3-L1 adipocytes. The cells were incubated for 7 days with various concentrations (0, 40, or 150 mg/ml) of CCC
after the induction of differentiation. Cell viability was measured on days 3, 5, and 7 using an MTT assay. The results were confirmed by three
independent experiments, which were each conducted in triplicate. The data are presented as the mean 6 SD.
doi:10.1371/journal.pone.0105809.g001
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higher level of lipid droplets than the undifferentiated cells, as
shown by the increase in intracellular triglyceride content
(Fig. 3D). The degree of lipid accumulation decreased with
increasing concentrations of CCC. Treatment with LY294002
significantly reduced the DMI-induced adipocyte differentiation of
3T3-L1 cells. Moreover, the triglyceride contents of 3T3-L1
adipocytes treated with a combination of 150 mg/mL CCC and
LY29400 was 55% of the cultures that were treated with CCC
alone (Fig. 3D). Thus, triglyceride accumulation was strongly
inhibited in the presence of CCC, suggesting that CCC prevented
adipocyte differentiation through the inhibition of the PI3K/Akt
signaling pathway in 3T3-L1 cells.
CCC reduced glucose uptake in 3T3-L1 adipocytes
We examined the effect of CCC on glucose uptake in 3T3-L1
adipocytes, using 2-NBDG. After reaching subconfluency, 3T3-L1
cells were incubated with differentiation medium in the presence
of various concentrations (10, 40, and 150 mg/ml) of CCC for 6
days. CCC inhibited the glucose uptake in a concentration
dependent manner and 35% reduction in insulin-stimulated
glucose uptake was observed at a concentration of 150 mg/ml
CCC (Fig. 3E).
CCC reduced the body weight and fat mass in HF-
induced obese rats
Treatment with CCC inhibited adipogenesis and adipocyte
differentiation in 3T3-L1 cells, suggesting that CCC attenuates
obesity induced by a high-fat diet (HFD). To determine whether
CC could regulate obesity, rats were fed a regular diet (RD), a
high-fat diet (HFD), a high-fat diet supplemented with 60 mg/kg
CCC (CCC 60), or a high-fat diet supplemented with 200 mg/kg
CCC (CCC 200) for 5 weeks. The high fat diet significantly
increased the rats’ body weight after 5 weeks in the HFD group
compared to the normal group (RD). This difference was present
after the first week and was maintained until the completion of the
study (Table 2). The body weight at week 5 was significantly
reduced in the CCC 60 and CCC 200 groups compared to that of
the HFD group (25% and 36%, respectively). Interestingly, despite
no significant differences in the daily food intake between the HFD
and HFD+ CCC groups, the CCC 200 group had a significantly
lower body weight that the HFD group. Remarkably, the
decreased weights of the epididymal and perirenal fat pads were
also observed when the rats were fed a diet supplemented with
CCC, indicating that CCC inhibited fat accumulation (Fig. 4A
and B). Furthermore, the perirenal fat pad masses in the CCC
groups were significantly reduced compared to the HFD group
(Fig. 4C). The effect of CCC on the epididymal fat weight was
determined by histological examination. The size of the adipocytes
in the epididymal fat of the CCC 200 group was significantly
smaller than in the HFD-induced obese rats (Fig. 4D). The
addition of CCC to the HFD negated the effect of HFD on liver
toxicity (data not shown).
CCC inhibited HFD-induced fat accumulation in the
liver. Haematoxylin and eosin staining was performed for
analysis of the effect of CCC on HFD-induced lipid accumulation
in the liver. Lipid accumulation was highly amplified in the HFD
group compared to the normal group (RD). Histological analysis
showed that HFD-fed rats developed hepatocellular micro- and
macrovesicular vacuolation as a result of fat accumulation
(Fig. 4E). However, the lipid accumulations induced by HFD
were significantly reduced in the HFD+CCC group, indicating
that CCC is capable of preventing lipid accumulation and hepatic
steatosis in HFD-induced fatty liver. Additionally, treatment of
CCC (200 mg/kg) caused a significant reduction in level of
hepatic TBARS as compared to the HFD group, suggesting that
CCC increased the antioxidant capacity in the liver of HFD-
induced obese rat (data not shown).
CCC reduced serum triglyceride (TG) and total-
cholesterol (TC) levels in the HFD-induced obese rats
To determine whether CCC has beneficial effects on the
circulating lipid profiles, we examined its effects on serum
triglyceride (TG) and total cholesterol (TC) levels. In a manner
similar to the increases observed in body weight and fat mass, the
serum levels of TG and TC in the HFD group were significantly
increased compared to the regular diet group (RD) (Fig. 5A and
C). However, treatment with CCC (CCC 200) caused a significant
reduction in the serum TG and TC levels by 32% and 46%,
respectively, compared with the rats that were given HFD alone.
Moreover, the serum high-density lipoprotein (HDL) cholesterol
levels were significantly increased in the CCC group compared to
the HFD group (Fig. 5B). Thus, the CCC extracts significantly
reduced the serum TG and TC levels and increased the HDL-
cholesterol levels in a dose-dependent manner. These results
indicated that CCC had tremendous anti-obesity effects in the
HFD-induced obese rats.
CCC inhibited adipogenesis gene expression in the HFD-
induced obese rats
Next, we examined the gene expression responsible for
lipogenesis in the epididymal fat tissue. In agreement of with our
in vitro cell culture studies, CCC decreased the phosphorylation of
Akt, whereas wild type Akt was expressed at similar levels in all of
the treated groups (Fig. 5D). The expression of PPARc was
Figure 2. CCC down-regulated the expression of the main adipogenesis and adipocyte-specific transcription factors during
adipocyte differentiation in 3T3-L1 preadipocytes. (A) Effects of CCC on PPARc, C/EBPa, C/EBPb, C/EBPd, aP2, LPL, and adiponectin mRNA
expression in 3T3-L1 cells. Confluent 3T3-L1 preadipocytes were induced to differentiate in the presence of different concentrations of CCC (from 0 to
150 mg/ml) for 7 days. Total RNA was isolated from 3T3-L1 adipocytes on days 3, 5 or 7 after the induction of differentiation, and gene expression
analysis was performed by RT-PCR. The amplification of b-actin was performed as a loading control. All of the experiments were performed in three
independent experiments. (B) The expression levels of adipogenesis and adipocyte-specific genes were determined during adipocyte differentiation
at day 7. The mRNA expression of PPARc, C/EBPa, C/EBPb, C/EBPd, aP2, and LPL were normalized using b-actin as a control. The bars with different
letters are significantly different (*p,0.05) as determined by Duncan’s multiple range test. (C) CCC reduced the protein levels of PPARc, C/EBPb, and
aP2 genes in 3T3-L1 adipocytes. Total protein was isolated from 3T3-L1 adipocytes on days 3, 5 or 7 after the induction of differentiation. Total cellular
proteins were immunoblotted for PPARc, C/EBPb, aP2, and b-actin, as indicated. Similar results were obtained from 3 replicates. (D) Effect of CCC on
PPARc mRNA expression in A549 lung cancer cells. A549 lung cancer cells were treated with 40 or 150 mg/ml CCC in the absence or presence of
rosiglitazone (10 mM) for 24 h in complete growth medium. Total RNA isolated from A549 cells was subjected to RT-PCR, and all of the gene
transcripts were normalized using b-actin as a control. The data represented the mean6 SD of 3 different experiments. *p,0.05, **P,0.01. (E) PPARc
and RXRa were cotransfected with the PPARc-Luc reporter construct into CHO cells for 24 h. The cells were treated with 100 mM rosiglitazone in the
absence or presence of CCC. After 24 h, luciferase activity was assayed. The data are the mean 6 SD values of at least three independent
experiments. The bars with different letters are significantly different (*p,0.05) as determined by Duncan’s multiple range test.
doi:10.1371/journal.pone.0105809.g002
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decreased in the CCC-treated rats in a dose-dependent manner
when compared to the HFD group (Fig. 5D).
Discussion
Obesity is induced by increases in adipose tissue mass, which
results from the multiplication of fat cells through adipogenesis and
increased deposition of cytoplasmic triglycerides [29]. A reduction
of adiposity is related to the inhibition of adipogenesis, along with
a reduction in the number of adipocytes and the lipid content (cell
size) of the adipocytes [30]. In the present study, we demonstrated
that CCCE significantly inhibited adipogenesis and adipocyte
differentiation in 3T3-L1 cells through the regulation of PPARc
activation and the Akt signaling pathway, leading to decreases in
body weight and fat tissue mass in HFD-induced obese rats.
Lipid accumulation reflects the differentiation of preadipocytes
into adipocytes, and this process is regulated by the increased
expression of various transcription factors and adipogenesis-
related genes [31]. The transcription factors in adipocytes play
critical roles in mediating adipogenesis and adipocyte differentia-
tion. The activation of C/EBPb and C/EBPd, which are key
adipogenic transcription factors, was rapidly induced during an
early stage of 3T3-L1 differentiation. C/EBPa and PPARc are
transcription factors expressed in the mid and late phases of
differentiation and are known to activate adipocyte genes during
the formation of mature adipocytes and to regulate insulin
sensitivity. Therefore, in this study, we investigated whether
CCC can affect adipocyte differentiation by measuring lipid
accumulation and the expression of several genes associated with
adipocyte differentiation and lipid metabolism in 3T3-L1 cells.
CCC treatment remarkably attenuated the level of Oil-Red O
staining in a dose-dependent manner, and microscopic inspection
also revealed a significant decrease in the levels of accumulated
intracellular triglycerides without affecting viability. This result
suggested that CCC inhibited adipogenesis during adipocyte
differentiation by causing an effective decrease in lipid formation
and by reducing lipid accumulation in 3T3-L1 adipocytes.
Moreover, CCC possesses the potential to down-regulate C/
EBPb, C/EBPd and PPARc mRNA expression in a concentra-
tion-dependent manner during the adipocyte differentiation of
3T3-L1 preadipocytes. Our data also showed that CCC markedly
decreased the protein levels of C/EBPb and PPARc compared to
fully differentiated adipocytes. Taken together, the lipid accumu-
lation was directly proportional to the expression levels of PPARc
and C/EBPs in these cells treated with different concentrations of
CCC. These results clearly implied that CCC had the ability to
suppress adipocyte differentiation through the down-regulation of
PPARc and the C/EBPs. The expression of C/EBPa was not
decreased by treatment with CCC, suggesting that the CCC-
mediated anti-adipogenesis effects were caused by the inactivation
of PPARc, but not C/EBPa.
PPARc is the master regulator of adipogenesis and controls the
adipogenic process. Forced expression of PPARc is sufficient to
induce adipocyte differentiation in fibroblasts, and no factor has
been discovered that promotes adipogenesis in the absence of
PPARc [12]. PPARc activates the expression of the downstream
adipocyte-specific genes aP2, LPL, and adiponectin [7,32]. In this
study, CCC significantly induced the down-regulation of PPARc
during 3T3-L1 differentiation, suggesting the inhibition of
adipogenic and adipocyte-specific genes, such as aP2, LPL, leptin,
and adiponectin. Therefore, we investigated the effect of CCC on
the regulation of the PPARc target genes, aP2, LPL, and
adiponectin. The expression levels of LPL, adiponectin, and aP2
were dose-dependently suppressed by treatment with CCC. LPL
catalyzes the hydrolysis reactions of triglycerides (TG), in which
plasma TGs are metabolized into free fatty acids for TG synthesis
by adipose cells [33]. Adiponectin is exclusively secreted from
adipose tissue, which results in increased glucose uptake and fatty
acid oxidation, and has been shown to improve insulin sensitivity
[34]. The aP2 gene is a terminal differentiation marker of
adipocytes, and it facilitates the cellular uptake of long-chain fatty
acids in a pathway linking fatty acid metabolism and obesity [35].
Thus, these results suggested that the down-regulation of aP2,
LPL, and adiponectin decreased fatty acid utilization and
triglyceride synthesis in 3T3-L1 cells, and this, in turn, was able
to inhibit adipocyte differentiation through the suppression of
PPARc activity. Moreover, CCC directly inhibited PPARc
transcriptional activity and preadipocyte differentiation in a
concentration-dependent manner. Therefore, our results strongly
suggested that CCC prevented adipogenesis through the inhibition
of the signaling pathways involving PPARc and through the
reduced expression of adipogenesis- and lipid metabolism-associ-
ated genes in 3T3-L1 adipocytes.
The insulin signaling pathway plays an essential role in 3T3-L1
adipocyte differentiation [36]. The serine/threonine kinase Akt is
particularly important in mediating adipocyte differentiation and
the metabolic actions of insulin. GSK3b is a critical downstream
signaling protein of the phosphoinositide 3-kinase (PI3K)/Akt
pathway. Several studies of Akt signaling have implicated it in the
regulation of PPARc expression and adipocyte differentiation
[12,36,37]. Moreover, Akt regulates adipogenesis via the phos-
phorylation and inactivation of substrates, such as GSK3b, which
directly regulates PPARc, C/EBPb, C/EBPa and b-catenin
[16,38]. We predict that cross talk between Akt/GSK3b and
PPARc signaling might be a possible target for CCC that results in
the disruption of adipocyte differentiation. In this study, these
results showed that the insulin-MDI mixture increased the
phosphorylation of Ser 473 on Akt and Ser 9 on GSK3b after
MDI addition. However, the serine phosphorylation of Akt was
Figure 3. Effects of CCC on the regulation of Akt and GSK3b during adipocyte differentiation. Confluent 3T3-L preadipocytes were
treated either with vehicle or CCC (0, 40, or 150 mg/ml) in the differentiation medium during day 0 to 7 of adipogenesis. (A) The protein level and the
degree of Akt phosphorylation were analyzed in 3T3-L1 cells on days 3, 5, and 7 after the induction of differentiation. These experiments were
conducted as independent experiments in triplicate. The data represent the mean 6 SD. *p,0.05. **P,0.01. (B) Effect of CCC on GSK3b activation in
3T3-L1 adipocytes. 3T3-L1 adipocytes were treated with CCC extracts at the indicated concentrations, and the phosphorylation levels of GSK3b were
determined by western blot analysis. The data are presented as the mean6 SD values of at least three independent experiments. *p,0.05. **P,0.01.
(C) Effect of CCC on Akt phosphorylation in A549 lung cancer cells. A549 lung cancer cells were treated with 40 or 150 mg/ml CCC in the absence or
presence of insulin (50 ng/ml) for 12 h. The representative Western bolts from one of three independent experiments were shown. (D) Effects of the
PI3K/Akt inhibitor LY294002 on the CCC-induced inhibition of adipocyte differentiation in 3T3-L1 cells. 3T3-L1 cells were treated with CCC during
differentiation in the presence or absence of 10 mM LY294002. The intracellular lipid accumulation was measured using a triglyceride assay. The data
are expressed as the mean 6 SD of three independent experiments. *P,0.05. (E) Effect of CCC on insulin-stimulated glucose uptake. Glucose uptake
activity was analyzed by measuring of 2-NBDG in differentiated 3T3-L1 cells. 3T3-L1 cells were induced to differentiate into adipocytes for 6 days in
DMI medium without or with CCC (10, 40, and 150 mg/m), and glucose uptake was then measured. The data are represented as the value relative to
that of the undifferentiated cells. The data are presented as the mean 6 SD from 3 independent experiments. *p,0.05. **P,0.01.
doi:10.1371/journal.pone.0105809.g003
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Figure 4. Treatment with CCC decreased the adipose tissue of the HFD-induced obese rats. The epididymal fat and perirenal fat weights
were significantly decreased in the HDF+CCC (200 mg/kg) group compared to the HFD group. (A) Effects of CCC on epididymal fat weight. The
weights of the epididymal fatty tissue were calculated by dividing the fatty tissue weight by the body weight (fatty tissue/body weight x 100). The
values are expressed as the mean 6 SD. The bars with different letters are significantly different (*p,0.05). (B) Effects of CCC on perirenal fat weight.
The values are expressed as the mean 6 SD. The bars showing different letters indicate significant differences among each group of bars, according
to Duncan’s test; *P,0.05. The means sharing a common letter do not significantly differ. (C) Morphology of the fat tissue altered by CCC in the HFD-
induced obese rats. (D) Histological staining of epididymal adipose tissue. Epididymal adipose tissues were isolated and stained with hematoxylin and
eosin (H&E), then examined microscopically. Representative micrographs showing the reduced adipocyte size in the HFD+CCC (200 mg/kg) group are
shown. (E) Representative H&E-stained liver section. Liver tissues were isolated and stained with H&E, then examined microscopically. Representative
micrographs showing the reduced number and size of lipid droplets in the HFD+CCC (200 mg/kg) group are shown.
doi:10.1371/journal.pone.0105809.g004
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decreased following CCC treatment in a dose-dependent manner,
which subsequently attenuated the levels of phosphorylated
GSK3b (Ser 9). These data indicated that inhibiting Akt
phosphorylation reduced the phosphorylation of the downstream
signaling components. Thus, our results strongly demonstrated
that insulin-mediated Akt phosphorylation and activation was
inhibited by treatment with CCC extract, which mainly affected
the reduced accumulation of triglycerides by inhibiting the PI3K/
Akt pathway during the differentiation of 3T3-L1 preadipocytes
into adipocytes. Interestingly, GSK3b is a critically important
protein kinase in adipocyte differentiation because it phosphory-
lates either C/EBPb or C/EBPa. The inhibition of GSK3b
phosphorylation (Ser 9) leads to C/EBPb phosphorylation and
inactivation [39], which is consistent with the negative regulation
of C/EBPb by GSK3b phosphorylation. Additionally, other
studies have demonstrated that the phosphorylation of GSK3b
(Ser 9) increases following insulin treatment, and its activity is
repressed by insulin and lithium chloride (LC) [40]. The addition
of LC to the differentiation medium of 3T3-L1 cells inhibited
PPARc expression and adipocyte differentiation [40]. Akt
signaling also promotes adipocyte differentiation through an
increase in PPARc expression [41]. Conversely, inhibition of the
Akt pathway in adipocyte differentiation has been shown to inhibit
adipogenesis by decreasing PPARc expression. The forced
expression of PPARc in Akt-deficient mouse embryonic fibroblasts
rescued their severe adipogenesis defect [12,37], which supports
the essential role of PPARc induction downstream of Akt.
Therefore, our results suggested that the expression of the major
transcription factor PPARc as associated with the Akt pathway,
and the inhibition of Akt phosphorylation and activation by CCC
blocked the insulin-induced adipocyte differentiation of 3T3-L1
preadipocytes. Moreover, co-treatment with the PI3K/Akt inhib-
itor LY294002 and CCC resulted in a more significant inhibitory
effect on triglyceride accumulation in 3T3-L1 cells when
compared to LY2904002 treatment alone. In addition to its
ability to block adipocyte differentiation of 3T3-L1 cells, we found
that CCC inhibited Akt phosphorylation and significantly reduced
insulin-stimulated glucose uptake, indicating that Akt was
definitely involved in the inhibitory effect of CCC on glucose
uptake in 3T3-L1 cells. Taken together, these results strongly
indicated that CCC suppressed the adipogenic induction of lipid
accumulation by inhibiting PPARc activation through the
suppression of the PI3K/Akt-signaling pathway during adipocyte
differentiation process.
In the present study, we also used the HFD-induced obesity rat
model to verify the anti-obesity effects of CCC extract in vivo. The
body weights of the HFD-induced obese rats were monitored after
daily oral administration of CCC at 60 or 200 mg/kg for 6 weeks.
Interestingly, CCC caused a decrease in weight gain in the HFD
rats after 6 weeks without affecting the food intake. Moreover, we
observed that rats fed a HFD supplemented with CCC had
significantly decreased levels of serum TG and TC compared with
rats fed a HFD alone, indicating that CCC efficiently regulated
TG and cholesterol metabolism in the HFD-induced obese rats.
This raises the possibility of an anti-obesity mechanism by which
CCC affects adipogenesis and energy expenditure. TC, which
represents a combination of low-and high-density lipoprotein
(LDL and HDL, respectively) cholesterol circulating in the blood,
is one of the most commonly examined measurements in a lipid
profile. HDL-cholesterol is considered good cholesterol, and high
levels of HDL are a good indicator of a healthy heart because less
cholesterol is available to attach to blood vessels; additionally,
HDL affects the cholesterol efflux capacity. In general, a HFD has
been associated with elevated serum LDL cholesterol and TGs
levels [42]. We demonstrated that rats fed a HFD had significantly
decreased serum HDL-cholesterol levels, while a HFD supple-
mented with CCC increased the serum HDL-cholesterol levels
compared to the regular diet (RD) rats.
Similar to its effect on serum TG, CCC remarkably lowered the
adipose tissue mass in rats fed a HFD supplemented with CCC
compared to rats fed a HFD alone. The total fat volume of the
epididymal and perirenal adipose tissues of representative HFD-
induced obese rats increased by 1.9-fold compared with that of
rats fed the regular diet (RD). However, the epididymal and
perirenal fat volume of the rats treated with 60 or 200 mg/kg of
CCC decreased by 15 or 25%, respectively, compared to that of
the HFD obese rat. The CCC supplement induced significant
losses in body weight, largely due to a reduction in epididymal and
perirenal fat tissues. This result was consistent with a previous
report, which demonstrated that the lipids in adipose tissue are
largely derived from circulating TGs, especially during HFD
feeding [43], and a reduction in serum TG levels also leads to
decreased adipose tissue mass [44]. In epididymal adipocyte tissue,
where the effects of CCC were observed most, treatment with
CCC reduced the adipocyte size and lipid accumulation.
Hypertrophy (large adipocyte) has been strongly correlated with
diet, whereas hyperplasia is dependent on genetics. Recent
evidence indicates that adipose tissue in mice exhibits dynamic
Table 2. Effects of CCC extracts on the body weight of HFD-induced obese rats.
Groups RD HFD HFD+CCC(60 mg/kg) HFD+CCC(200 mg/kg)
Body weight gain (g/weeks)
1st week 38.663.22 50.864.1** 46.762.56a 44.263.35a
2nd week 36.463.25 53.664.15** 48.563.87a 45.664.23b
3rd week 37.863.42 57.663.65** 50.664.52a 44.663.57b
4th week 39.664.33 60.564.55** 54.565.02a 46.863.98b
5th week 35.864.22 55.364.83** 49.564.36a 44.764.07b
6th week 34.563.48 56.563.25** 48.764.28a 43.663.18b
The results are presented as the mean6 SD. RD, regular diet-fed rat; HFD, high-fat diet-fed rat; HFD+CCC (60 mg/kg), high-fat diet containing 60 mg/kg BW CCC-fed rat;
HFD+CCC (200 mg/kg), high-fat diet containing 200 mg/kg BW CCC-fed rat. The body weight was measured twice a week. Results are presented as the means 6 SD.
aP,0.05,
bP,0.01 compared to the HFD group;
**P,0.01 compared to the RD group.
doi:10.1371/journal.pone.0105809.t002
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remodeling when the animals are maintained on a HFD, with
marked changes in adipocyte cell number and size occurring after
high fat feeding [45]. In this study, a high fat diet caused the
hypertrophy of the adipocytes, and treatment with CCC strongly
reduced the hypertrophy in the HFD rats. In the liver of HFD-fed
rat, we found that the HFD supplemented by CCC dramatically
reduced hepatic lipid accumulation compared to HFD alone.
Taken together, we suggested that the reduction of adipose tissue
mass in rats fed a HFD supplemented with CCC caused the
significant reductions in body weight gain, indicating that CCC
administration influenced adipose tissue metabolism in obese rats.
The differences in fat weight between the HDF and HFD+CCC
rats might be due to the size of the adipocytes, which reflects the
amount of lipid accumulation in the adipocytes. Importantly,
CCC significantly down-regulated the expression of PPARc and
the phosphorylation of Akt in the HFD rats, which might be
mechanisms that prevent the HFD-induced obese rats from
gaining weight.
Numerous studies have indicated that various natural extracts
inhibit body fat and lipid accumulation in vitro and in vivo. This
study showed that CCC has an inhibitory effect on HFD-induced
obesity. Although several studies have reported that CC extract
exerts a variety of pharmacological activities, including hypolip-
idemic, antitumor, and antibacterial activities, no study has
Figure 5. Effect of CCC on the lipid contents of the HFD-induced obese rats. (A, B, C) Significant decreases in the levels of serum
triglycerides and total cholesterol were observed in the CCC-treated groups compared to the HFD-induced obese rats. HDL-cholesterol levels in the
CCC groups were increased compared to the HFD group. The values are expressed as the mean 6 SD. The bars showing different letters indicate
significant differences among each group of bars, according to Duncan’s test; *P,0.05. (D) CCC reduced the phosphorylation of Akt and the
expression of PPARc in the HFD-induced obese rats. PPARc and phospho-Akt protein expression in the epididymal fat tissue was determined by
western blot analysis.
doi:10.1371/journal.pone.0105809.g005
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examined the ability of CCC to prevent obesity in 3T3-L1 cells
and HFD obese rats. In this study, we found that CCC contained
high total phenolic and flavonoid contents and was effective at
scavenging for DPPH, superoxide anion, and hydroxyl radicals,
which correlated with its antioxidant potential. Considering a
potential use of antioxidant substances as anti-obesity agents, the
antioxidant potential of CCC can prevent adipocyte differentia-
tion in 3T3-L1 cells and HFD obese fat tissues.
In the present study, we investigated the anti-obesity effects of
CCC on adipocyte differentiation and associated mechanisms in
3T3-L1 cells and confirmed our finding in an obese rat model fed
a HFD. CCC greatly reduced the expression of C/EBPb and C/
EBPd and subsequently down-regulated the activation of the key
transcriptional regulator PPARc in 3T3-L1 adipocytes. The levels
of Akt and GSK3b phosphorylation were significantly attenuated
by CCC treatment, which blocked adipogenesis and adipocyte
differentiation in 3T3-L1 cells. Moreover, the administration of
CCC effectively suppressed HFD-induced body weight gain and
decreased the body fat and lipid content in the tissues of the rats.
These studies indicated that the anti-obesity effects of CCC were
accompanied by a significant decrease in phospho-Akt and
PPARc expression in HFD tissues, thus suggesting that CCC
has the ability to prevent HFD-induced obesity, possibly through
the activation of Akt and PPARc signaling. These results suggested
that the anti-obesity effect of CCC results from a decrease in
adipogenesis and that CCC is a good candidate for an anti-obesity
agent.
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